View in EDS HTML Full Text PDF Full Text

Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies.

Saved in:
Bibliographic Details
Title: Real-world evidence of Trastuzumab Deruxtecan (T-DXd) Efficacy in HER2-expressing gynecological malignancies.
Authors: Andrikopoulou, Angeliki1 (AUTHOR) aggelikiandrikop@gmail.com, Zagouri, Flora1 (AUTHOR) florazagouri@yahoo.co.uk, Goula, Kallirroi2 (AUTHOR) kallirroigoula8@gmail.com, Haidopoulos, Dimitrios3 (AUTHOR) dimitrioshaidopoulos@gmail.com, Thomakos, Nikolaos3 (AUTHOR) nthomakos@med.uoa.gr, Svarna, Anna1 (AUTHOR) anna.svarna@hotmail.com, Dimopoulos, Meletios-Athanasios1 (AUTHOR) mdimop@med.uoa.gr, Liontos, Michalis1 (AUTHOR) mliontos@gmail.com
Source: BMC Cancer. 12/5/2024, Vol. 24 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-024-13226-1